NCT06148779 Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care
| NCT ID | NCT06148779 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Joint Academy |
| Condition | Health Services Accessibility |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2022-01-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To improve chronically ill patients' health and quality of life, long-standing and continuous treatment is needed at an acceptable cost. The purpose of this study was to compare utilization of digital versus face-to-face delivered osteoarthritis (OA) treatment in the 21 different county councils of Sweden that are responsible for providing healthcare to the residents.
Eligibility Criteria
\* Patients in the Joint Academy database that had participated in the Joint Academy treatment program for OA and given their informed consent to participate in research. Inclusion criteria for the treatment program: * Radiographic and or clinical diagnosis of hip or knee OA from a physical therapist or physician (95% of all patients in previously published studies). Individuals without a prior diagnosis had clinical OA confirmed by an orthopaedic surgeon or physiotherapist via telephone (diagnosis according to National Institute for Health and Care Excellence (NICE) criteria and Swedish National Guidelines, and confirming the absence of any red flag symptoms), or if deemed necessary were recommended to seek face-to-face care before inclusion in the programme. * From October 1st 2021, all patients should have undergone a physical examination by doctor or physiotherapists before being able to enter the treatment.
Contact & Investigator
Leif E Dahlberg, Senior professor
STUDY DIRECTOR
Joint Academy
Frequently Asked Questions
Who can join the NCT06148779 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health Services Accessibility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06148779 currently recruiting?
Yes, NCT06148779 is actively recruiting participants. Contact the research team at leif@jointacademy.com for enrollment information.
Where is the NCT06148779 trial being conducted?
This trial is being conducted at Malmö, Sweden.
Who is sponsoring the NCT06148779 clinical trial?
NCT06148779 is sponsored by Joint Academy. The principal investigator is Leif E Dahlberg, Senior professor at Joint Academy. The trial plans to enroll 50,000 participants.